P37231 PPARG_HUMAN
Gene name: PPARG
Protein name: Peroxisome proliferator-activated receptor gamma
List of molecules and drugs that target protein P37231
# | DrugDomain Data | DrugBank Accession | Name | Drug action | Affinity data | InChI Key | SMILES |
---|---|---|---|---|---|---|---|
1 | P37231_DB00132 | DB00132 | alpha-Linolenic acid | n/a | IC50(nM) = 6000.0 Kd(nM) = 2000.0 | DTOSIQBPPRVQHS-PDBXOOCHSA-N | CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O |
2 | P37231_DB00159 | DB00159 | Icosapent | agonist | IC50(nM) = 1600.0 Kd(nM) = 2000.0 | JAZBEHYOTPTENJ-JLNKQSITSA-N | CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O |
3 | P37231_DB00197 | DB00197 | Troglitazone | agonist | Ki(nM) = 302.0 EC50(nM) = 537.0 | GXPHKUHSUJUWKP-UHFFFAOYSA-N | CC1=C(C)C2=C(CCC(C)(COC3=CC=C(CC4SC(=O)NC4=O)C=C3)O2)C(C)=C1O |
4 | P37231_DB00244 | DB00244 | Mesalazine | agonist | KBOPZPXVLCULAV-UHFFFAOYSA-N | NC1=CC(C(O)=O)=C(O)C=C1 | |
5 | P37231_DB00313 | DB00313 | Valproic acid | n/a | NIJJYAXOARWZEE-UHFFFAOYSA-N | CCCC(CCC)C(O)=O | |
6 | P37231_DB00328 | DB00328 | Indomethacin | activator | EC50(nM) = 50000.0 | CGIGDMFJXJATDK-UHFFFAOYSA-N | COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O |
7 | P37231_DB00412 | DB00412 | Rosiglitazone | agonist | Ki(nM) = 8.0 IC50(nM) = 7.7 Kd(nM) = 1.2 EC50(nM) = 1.0 koff(s-1) = 0.145 | YASAKCUCGLMORW-UHFFFAOYSA-N | CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1 |
8 | P37231_DB00573 | DB00573 | Fenoprofen | n/a | RDJGLLICXDHJDY-UHFFFAOYSA-N | CC(C(O)=O)C1=CC(OC2=CC=CC=C2)=CC=C1 | |
9 | P37231_DB00731 | DB00731 | Nateglinide | agonist | OELFLUMRDSZNSF-BRWVUGGUSA-N | CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@H](CC1=CC=CC=C1)C(O)=O | |
10 | P37231_DB00845 | DB00845 | Clofazimine | modulator | WDQPAMHFFCXSNU-BGABXYSRSA-N | CC(C)N=C1C=C2N(C3=CC=C(Cl)C=C3)C3=C(C=CC=C3)N=C2C=C1NC1=CC=C(Cl)C=C1 | |
11 | P37231_DB00912 | DB00912 | Repaglinide | agonist | FAEKWTJYAYMJKF-QHCPKHFHSA-N | CCOC1=C(C=CC(CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N2CCCCC2)=C1)C(O)=O | |
12 | P37231_DB00966 | DB00966 | Telmisartan | partial agonist | IC50(nM) = 12200.0 EC50(nM) = 700.0 | RMMXLENWKUUMAY-UHFFFAOYSA-N | CCCC1=NC2=C(C=C(C=C2C)C2=NC3=CC=CC=C3N2C)N1CC1=CC=C(C=C1)C1=CC=CC=C1C(O)=O |
13 | P37231_DB01014 | DB01014 | Balsalazide | agonist | IPOKCKJONYRRHP-FMQUCBEESA-N | OC(=O)CCNC(=O)C1=CC=C(C=C1)\N=N\C1=CC=C(O)C(=C1)C(O)=O | |
14 | P37231_DB01050 | DB01050 | Ibuprofen | activator | HEFNNWSXXWATRW-UHFFFAOYSA-N | CC(C)CC1=CC=C(C=C1)C(C)C(O)=O | |
15 | P37231_DB01067 | DB01067 | Glipizide | agonist | ZJJXGWJIGJFDTL-UHFFFAOYSA-N | CC1=NC=C(N=C1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1 | |
16 | P37231_DB01118 | DB01118 | Amiodarone | agonist | IYIKLHRQXLHMJQ-UHFFFAOYSA-N | CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2 | |
17 | P37231_DB01132 | DB01132 | Pioglitazone | agonist | Ki(nM) = 62.0 IC50(nM) = 720.0 Kd(nM) = 871.0 EC50(nM) = 98.0 | HYAFETHFCAUJAY-UHFFFAOYSA-N | CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1 |
18 | P37231_DB01252 | DB01252 | Mitiglinide | agonist | WPGGHFDDFPHPOB-BBWFWOEESA-N | [H][C@@](CC(=O)N1C[C@@]2([H])CCCC[C@@]2([H])C1)(CC1=CC=CC=C1)C(O)=O | |
19 | P37231_DB01393 | DB01393 | Bezafibrate | agonist | EC50(nM) = 3000.0 | IIBYAHWJQTYFKB-UHFFFAOYSA-N | CC(C)(OC1=CC=C(CCNC(=O)C2=CC=C(Cl)C=C2)C=C1)C(O)=O |
20 | P37231_DB02266 | DB02266 | Flufenamic acid | agonist | LPEPZBJOKDYZAD-UHFFFAOYSA-N | OC(=O)C1=CC=CC=C1NC1=CC(=CC=C1)C(F)(F)F | |
21 | P37231_DB02709 | DB02709 | Resveratrol | n/a | EC50(nM) = 77100.0 | LUKBXSAWLPMMSZ-OWOJBTEDSA-N | OC1=CC=C(\C=C\C2=CC(O)=CC(O)=C2)C=C1 |
22 | P37231_DB02746 | DB02746 | Phthalic Acid | n/a | XNGIFLGASWRNHJ-UHFFFAOYSA-N | OC(=O)C1=CC=CC=C1C(O)=O | |
23 | P37231_DB03600 | DB03600 | Capric acid | ligand | GHVNFZFCNZKVNT-UHFFFAOYSA-N | CCCCCCCCCC(O)=O | |
24 | P37231_DB03756 | DB03756 | Doconexent | activator | MBMBGCFOFBJSGT-KUBAVDMBSA-N | CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O | |
25 | P37231_DB04224 | DB04224 | Oleic Acid | ligand | ZQPPMHVWECSIRJ-MDZDMXLPSA-N | CCCCCCCC\C=C\CCCCCCCC(O)=O | |
26 | P37231_DB04270 | DB04270 | (S)-3-(4-(2-Carbazol-9-Yl-Ethoxy)-Phenyl)-2-Ethoxy-Propionic Acid | n/a | Kd(nM) = 170.0 EC50(nM) = 170.0 | WUZIMDSVRIBNNI-DEOSSOPVSA-N | [H][C@@](CC1=CC=C(OCCN2C3=C(C=CC=C3)C3=C2C=CC=C3)C=C1)(OCC)C(O)=O |
27 | P37231_DB04689 | DB04689 | 2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID | n/a | IC50(nM) = 50.0 EC50(nM) = 70.0 | ZXWVCCFKIRBLDP-UHFFFAOYSA-N | CCCC1=C(OCCCOC2=CC3=C(C=C2)N(CC(O)=O)C=C3)C=CC2=C1C=CC(=C2)C(=O)C1=CC=CC=C1 |
28 | P37231_DB04971 | DB04971 | Reglitazar | n/a | QBQLYIISSRXYKL-UHFFFAOYSA-N | CC1=C(CCOC2=CC=C(CC3C(=O)NOC3=O)C=C2)N=C(O1)C1=CC=CC=C1 | |
29 | P37231_DB05187 | DB05187 | Elafibranor | n/a | AFLFKFHDSCQHOL-IZZDOVSWSA-N | CSC1=CC=C(C=C1)C(=O)\C=C\C1=CC(C)=C(OC(C)(C)C(O)=O)C(C)=C1 | |
30 | P37231_DB05490 | DB05490 | AMG-131 | partial agonist | NMRWDFUZLLQSBN-UHFFFAOYSA-N | ClC1=CC=C(C(Cl)=C1)S(=O)(=O)NC1=CC(Cl)=C(OC2=CN=C3C=CC=CC3=C2)C(Cl)=C1 | |
31 | P37231_DB06510 | DB06510 | Muraglitazar | n/a | IRLWJILLXJGJTD-UHFFFAOYSA-N | COC1=CC=C(OC(=O)N(CC(O)=O)CC2=CC=C(OCCC3=C(C)OC(=N3)C3=CC=CC=C3)C=C2)C=C1 | |
32 | P37231_DB06521 | DB06521 | Ertiprotafib | n/a | FONCZICQWCUXEB-RUZDIDTESA-N | CC1=C(C)C2=C(C3=CC(C)=C(O[C@H](CC4=CC=CC=C4)C(O)=O)C(C)=C3)C3=CC=CC=C3C(Br)=C2S1 | |
33 | P37231_DB06533 | DB06533 | Ragaglitazar | n/a | WMUIIGVAWPWQAW-XMMPIXPASA-N | CCO[C@H](CC1=CC=C(OCCN2C3=CC=CC=C3OC3=C2C=CC=C3)C=C1)C(O)=O | |
34 | P37231_DB06536 | DB06536 | Tesaglitazar | n/a | CXGTZJYQWSUFET-IBGZPJMESA-N | CCO[C@@H](CC1=CC=C(OCCC2=CC=C(OS(C)(=O)=O)C=C2)C=C1)C(O)=O | |
35 | P37231_DB06908 | DB06908 | (2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID | n/a | PAWOPJKHTZCKMT-QFIPXVFZSA-N | [H][C@@](CC1=CC2=C(C=C1)N(CC1=C(C)OC(=N1)C1=C(Cl)C=CC=C1)C=C2)(OCC)C(O)=O | |
36 | P37231_DB06926 | DB06926 | (9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid | n/a | HNICUWMFWZBIFP-IRQZEAMPSA-N | [H][C@](O)(CCCCC)\C=C\C=C/CCCCCCCC(O)=O | |
37 | P37231_DB07053 | DB07053 | 2-{5-[3-(7-PROPYL-3-TRIFLUOROMETHYLBENZO[D]ISOXAZOL-6-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID | n/a | IC50(nM) = 152.0 EC50(nM) = 230.0 | TWVYNPULGKGJOS-UHFFFAOYSA-N | CCCC1=C2ON=C(C2=CC=C1OCCCOC1=CC2=C(C=C1)N(CC(O)=O)C=C2)C(F)(F)F |
38 | P37231_DB07111 | DB07111 | (4S,5E,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid | n/a | IFRKCNPQVIJFAQ-HBUOOPIGSA-N | [H][C@](O)(CCC(O)=O)\C=C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC | |
39 | P37231_DB07172 | DB07172 | (5R,6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid | n/a | FTAGQROYQYQRHF-CBVHGRPESA-N | [H][C@@](O)(CCCC(O)=O)\C=C\C=C/C\C=C/C\C=C/C\C=C/CC | |
40 | P37231_DB07208 | DB07208 | (8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8,12-dienoic acid | n/a | OJFOOCZBVPQYRS-PSDPTOBYSA-N | [H][C@](O)(C\C=C/CCCCC)\C=C\CC(=O)CCCCC(O)=O | |
41 | P37231_DB07209 | DB07209 | (8R,9Z,12Z)-8-hydroxy-6-oxooctadeca-9,12-dienoic acid | n/a | MLHUENSFQCPBQH-ZBKJIUGYSA-N | [H][C@@](O)(CC(=O)CCCCC(O)=O)\C=C/C\C=C/CCCCC | |
42 | P37231_DB07302 | DB07302 | 9(S)-HODE | n/a | NPDSHTNEKLQQIJ-UINYOVNOSA-N | CCCCC\C=C/C=C/[C@@H](O)CCCCCCCC(O)=O | |
43 | P37231_DB07509 | DB07509 | difluoro(5-{2-[(5-octyl-1H-pyrrol-2-yl-kappaN)methylidene]-2H-pyrrol-5-yl-kappaN}pentanoato)boron | n/a | JNKJCLYKBRBEKW-UHFFFAOYSA-N | CCCCCCCCC1=CC=C2C=C3C=CC(CCCCC(O)=O)=[N+]3[B-](F)(F)N12 | |
44 | P37231_DB07675 | DB07675 | (2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACID | n/a | Ki(nM) = 90.0 IC50(nM) = 92.0 EC50(nM) = 570.0 | WMUIIGVAWPWQAW-DEOSSOPVSA-N | [H][C@@](CC1=CC=C(OCCN2C3=C(OC4=C2C=CC=C4)C=CC=C3)C=C1)(OCC)C(O)=O |
45 | P37231_DB07723 | DB07723 | 3-(5-methoxy-1H-indol-3-yl)propanoic acid | n/a | ZLSZCJIWILJKMR-UHFFFAOYSA-N | COC1=CC=C2NC=C(CCC(O)=O)C2=C1 | |
46 | P37231_DB07724 | DB07724 | Indeglitazar | n/a | YMPALHOKRBVHOJ-UHFFFAOYSA-N | COC1=CC=C(C=C1)S(=O)(=O)N1C=C(CCC(O)=O)C2=CC(OC)=CC=C12 | |
47 | P37231_DB07842 | DB07842 | (2S)-2-(4-ethylphenoxy)-3-phenylpropanoic acid | n/a | EC50(nM) = 3600.0 | CJMVTSLLWMPEKQ-INIZCTEOSA-N | [H][C@@](CC1=CC=CC=C1)(OC1=CC=C(CC)C=C1)C(O)=O |
48 | P37231_DB07863 | DB07863 | 2-chloro-5-nitro-N-phenylbenzamide | n/a | EC50(nM) = 2.0 | DNTSIBUQMRRYIU-UHFFFAOYSA-N | [O-][N+](=O)C1=CC=C(Cl)C(=C1)C(=O)NC1=CC=CC=C1 |
49 | P37231_DB08121 | DB08121 | (2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid | n/a | EC50(nM) = 480.0 | TZTPJJNNACUQQR-FQEVSTJZSA-N | [H][C@@](CC1=CC=CC=C1)(OC1=CC=C(C=C1)C1=CC=CC=C1)C(O)=O |
50 | P37231_DB08302 | DB08302 | 3-[5-(2-nitropent-1-en-1-yl)furan-2-yl]benzoic acid | n/a | IRHZCQDCMUWUKV-RAXLEYEMSA-N | CCC\C(=C\C1=CC=C(O1)C1=CC(=CC=C1)C(O)=O)[N+]([O-])=O | |
51 | P37231_DB08402 | DB08402 | 2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID | n/a | EC50(nM) = 1300.0 | VNDRRWBKNSHALL-UHFFFAOYSA-N | OC(=O)C1=C(NC(=O)C2=C(Cl)C=C(Cl)C=C2)C=CC(OC2=NC=CC=N2)=C1 |
52 | P37231_DB08435 | DB08435 | (5E,14E)-11-oxoprosta-5,9,12,14-tetraen-1-oic acid | n/a | VHRUMKCAEVRUBK-XOVNXQNQSA-N | [H][C@]1(C\C=C\CCCC(O)=O)C=CC(=O)\C1=C/C=C/CCCCC | |
53 | P37231_DB08560 | DB08560 | 3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE | n/a | IC50(nM) = 512.0 EC50(nM) = 1750.0 | GULUFDCOGAXLEP-UHFFFAOYSA-N | FC1=CC=C(C=C1)N1N=C(C=C1NS(=O)(=O)C1=CC=CC(F)=C1)C1=CC=CS1 |
54 | P37231_DB08604 | DB08604 | Triclosan | n/a | XEFQLINVKFYRCS-UHFFFAOYSA-N | OC1=CC(Cl)=CC=C1OC1=C(Cl)C=C(Cl)C=C1 | |
55 | P37231_DB08760 | DB08760 | (2S)-2-(4-chlorophenoxy)-3-phenylpropanoic acid | n/a | EC50(nM) = 2692.0 | CPBLTMSKPQDJPW-AWEZNQCLSA-N | [H][C@@](CC1=CC=CC=C1)(OC1=CC=C(Cl)C=C1)C(O)=O |
56 | P37231_DB08915 | DB08915 | Aleglitazar | agonist | IC50(nM) = 19.0 EC50(nM) = 21.0 | DAYKLWSKQJBGCS-NRFANRHFSA-N | CO[C@@H](CC1=CC=C(OCCC2=C(C)OC(=N2)C2=CC=CC=C2)C2=C1SC=C2)C(O)=O |
57 | P37231_DB09006 | DB09006 | Clinofibrate | n/a | BMOVQUBVGICXQN-UHFFFAOYSA-N | CCC(C)(OC1=CC=C(C=C1)C1(CCCCC1)C1=CC=C(OC(C)(CC)C(O)=O)C=C1)C(O)=O | |
58 | P37231_DB09061 | DB09061 | Cannabidiol | activator | QHMBSVQNZZTUGM-ZWKOTPCHSA-N | CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1 | |
59 | P37231_DB09198 | DB09198 | Lobeglitazone | activator | CHHXEZSCHQVSRE-UHFFFAOYSA-N | COC1=CC=C(OC2=NC=NC(=C2)N(C)CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1 | |
60 | P37231_DB09201 | DB09201 | Ciglitazone | agonist | IC50(nM) = 5000.0 EC50(nM) = 3000.0 | YZFWTZACSRHJQD-UHFFFAOYSA-N | CC1(COC2=CC=C(CC3SC(=O)NC3=O)C=C2)CCCCC1 |
61 | P37231_DB09213 | DB09213 | Dexibuprofen | activator | HEFNNWSXXWATRW-JTQLQIEISA-N | CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O | |
62 | P37231_DB11672 | DB11672 | Curcumin | n/a | VFLDPWHFBUODDF-FCXRPNKRSA-N | COC1=CC(\C=C\C(=O)CC(=O)\C=C\C2=CC(OC)=C(O)C=C2)=CC=C1O | |
63 | P37231_DB11811 | DB11811 | Arhalofenate | n/a | BJBCSGQLZQGGIQ-QGZVFWFLSA-N | CC(=O)NCCOC(=O)[C@H](OC1=CC=CC(=C1)C(F)(F)F)C1=CC=C(Cl)C=C1 | |
64 | P37231_DB12007 | DB12007 | Isoflavone | agonist | GOMNOOKGLZYEJT-UHFFFAOYSA-N | O=C1C(=COC2=CC=CC=C12)C1=CC=CC=C1 | |
65 | P37231_DB12662 | DB12662 | Naveglitazar | n/a | OKJHGOPITGTTIM-DEOSSOPVSA-N | CO[C@@H](CC1=CC=C(OCCCOC2=CC=C(OC3=CC=CC=C3)C=C2)C=C1)C(O)=O | |
66 | P37231_DB13873 | DB13873 | Fenofibric acid | n/a | MQOBSOSZFYZQOK-UHFFFAOYSA-N | CC(C)(OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1)C(O)=O | |
67 | P37231_DB14011 | DB14011 | Nabiximols | n/a | SSNHGLKFJISNTR-DYSNNVSPSA-N | [H][C@]1(CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1O)C(C)=C.[H][C@@]12CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1OC2(C)C | |
68 | P37231_DB14034 | DB14034 | Darglitazone | agonist | QQKNSPHAFATFNQ-UHFFFAOYSA-N | CC1=C(CCC(=O)C2=CC=C(CC3SC(=O)NC3=O)C=C2)N=C(O1)C1=CC=CC=C1 | |
69 | P37231_DB14635 | DB14635 | Curcumin sulfate | n/a | NEJVQQBBTRFOHB-FCXRPNKRSA-N | COC1=CC(\C=C\C(=O)CC(=O)\C=C\C2=CC=C(OS(O)(=O)=O)C(OC)=C2)=CC=C1O |